Drawing for APILIFE

USPTO serial 79342908

APILIFE

Reviewed by CopyMark Law Group

Reg. 7251158Status 700Registered
Filing date
Status date
Registration date
Dec 26, 2023
Examiner
LOZEAU, BRANDON THOMAS
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with APILIFE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stephanie N. Nikitenko

Stephanie N. Nikitenko IpHorgan Ltd195 Arlington Heights Rd, Suite #125Buffalo Grove, IL 60089UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Downloadable mobile applications for collecting medical data and information; downloadable application software for collecting medical data and information; downloadable computer software for collecting medical data and information; all the aforementioned goods being exclusively related to health software for use in tracking and remotely monitoring patients suffering with chronic conditionsACTIVE—
010Microsensors for medical purposes for measuring human body data; wearable monitors for measuring biometric data for medical use; portable monitors used for measuring biometric data for medical use; microsensor probes for medical use for analyzing human body dataACTIVE—
035Automatic processing of medical data being data processing services; compilation of statistical data for use in scientific or medical research; all the aforementioned services being exclusively related to health software for use in tracking and remotely monitoring patients suffering with chronic conditionsACTIVE—
042Design and development of computer software for data collection, transmission and analysis; providing information in the form of data with respect to medical and veterinary research and development; all the aforementioned services being exclusively related to health software for use in tracking and remotely monitoring patients suffering with chronic conditionsACTIVE—
044Providing medical information; medical assistance; all the aforementioned services being exclusively related to health software for use in tracking and remotely monitoring patients suffering with chronic conditionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 14, 2025CHLDCHANGE OF OWNER RECEIVED FROM IB—
Apr 23, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 29, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 28, 2024FIMPFINAL DISPOSITION PROCESSED—
Mar 26, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 26, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 26, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 11, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Nov 22, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 22, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 10, 2023GPNXNOTIFICATION PROCESSED BY IB—
Oct 10, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 10, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 20, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 20, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 20, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 5, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 1, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Sep 1, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 1, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 1, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 23, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 22, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 22, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 25, 2023RFNTREFUSAL PROCESSED BY IB—
Mar 31, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 31, 2023RFRRREFUSAL PROCESSED BY MPU—
Feb 14, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 13, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 13, 2023DOCKASSIGNED TO EXAMINER—
Jun 22, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 18, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 16, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance